NCT04117659View on ClinicalTrials.gov

Phosphodiesterase-5-inhibitors for Right Heart Failure After Left Ventricular Assist Device Implantation

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

February 26, 2021

Study Completion Date

March 15, 2021

Conditions
Phosphodiesterase Inhibitor Adverse ReactionRight-Sided Heart Failure
Interventions
OTHER

withdrawal of oral medication (phosphodiesterase-5 inhibitor) in pretreated patients

discontinuation of the oral medication with a phosphodiesterase-5 inhibitor

Trial Locations (1)

45122

University Hospital Essen, Essen

All Listed Sponsors
lead

University Hospital, Essen

OTHER

NCT04117659 - Phosphodiesterase-5-inhibitors for Right Heart Failure After Left Ventricular Assist Device Implantation | Biotech Hunter | Biotech Hunter